BDSX
BIODESIX INC
Key Financials
Net Income
$-35265000
↑ 17.9%
Operating Income
$-27873000
↑ 19.2%
EPS (Diluted)
$-4.67
↓ 1315.2%
Revenue
$88.5M
↑ 24.1%
Total Liabilities
$89.9M
↑ 17.8%
Total Assets
$87.5M
↓ 10.0%
Shareholders' Equity
$-2465000.00
↓ 111.8%
Cash & Equivalents
$19.0M
↓ 27.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| SCHEDULE 13G/A | 5/8/2026 | View on SEC |
| 10-Q | 5/4/2026 | View on SEC |
| 8-K | 5/4/2026 | View on SEC |
| SCHEDULE 13G | 4/28/2026 | View on SEC |
| ARS | 4/9/2026 | View on SEC |
| DEFA14A | 4/9/2026 | View on SEC |
| DEF 14A | 4/9/2026 | View on SEC |
| 4 | 4/2/2026 | View on SEC |
| 10-K | 2/26/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BDSX |
| Company Name | BIODESIX INC |
| CIK | 1439725 |
| Sector | Services-Medical Laboratories |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 8071 |
| SIC Description | Services-Medical Laboratories |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 303-417-0500 |